The vitamin market is experiencing shifting sentiment as prices begin to rise, driven by geopolitical tensions and concerns over raw material supply. While some vitamins remain stable, many suppliers have increased prices or reduced offerings, fuelling further speculation. Buyers are moving to secure contracts ahead of further possible volatility, particularly for the upcoming quarters.
In partnership with Feed Additive Prices
Vitamin E 50%
The market sentiment has changed, and prices have started to increase. The geopolitical situation, a potential raw material shortage, and a long-standing desire by manufacturers to increase the price are now all coming together. The actual increase and the actual transactions are still difficult to judge, and there is a lot of speculation right now. With the current geopolitical situation, there might be more momentum for a further price increase. Several suppliers have now stopped offering or increased their prices again.
Vitamin A 1000
There is a similar pattern for vitamin A as for vitamin E. Suppliers have either increased prices or are refraining from offering altogether. It gives a firmer sentiment to the market, but it seems that one supplier is still keen to regain market share and is not increasing prices yet, like the others are doing. There is a good contract cover on Q2, but in case the geopolitical situation continues in the same way, then things may change and move forward to Q3.
Vitamin D3 500
Market sentiment has shifted slightly toward a more bullish stance. Prices have recently declined but remain relatively high, and several regions have consequently experienced a decrease in material imports. This has created a more balanced supply and demand dynamic that has contributed to price stability. But now, with all the geopolitical tension, buyers are concerned about future availability and have started to secure material in advance. This has led to slightly increasing prices. Most of Q2 is contracted by now, and a portion of Q3 is as well.
Vitamin B2 80%
Although several vitamins have either stopped declining in price or are increasing as a result of the current geopolitical situation, the vitamin B2 market has so far stayed calm and steady in price in most regions. Most of Q2 has been contracted by now, and even a small overlap into Q3 is seen.
D-Calpan
After a significant period of stable to weak prices, some increase is now seen. Buyers have started to cover Q2 and Q3 as they are not certain how the pipeline is filled, and they want to secure material under the current global geopolitical situation. The market has become active, and suppliers have increased prices somewhat.
Vitamin B3
As the supply of raw materials is potentially disrupted due to the current geopolitical situation, the market has become active. Recently, prices had stabilised after a slight increase. And now prices are slowly moving up further, although nothing significant has happened yet. There was already a good cover on Q2, and that is now being extended into Q3.
Biotin
So far, the biotin market has stayed calm, and prices have been stable. It is mostly pure biotin, which is being exported from China, and the firmer container freight has no impact, really. As with many feed additives originating in China, things may change depending on the geopolitical development, but right now this product is not moving on price. A good portion of Q2 is contracted by now, and a portion of Q3 is as well.
Vitamin C 35% mono
New attempts by manufacturers to increase prices for new business are seen, mostly related to expected increased freight costs for export shipments from China. So far, the market has not really reacted, and prices have remained relatively stable. Q2 has been mostly contracted already.
